Choosing a cancer screening center in Haryana requires verifying equipment claims beyond marketing promises. AERB licensing for PET-CT scanners, NABL pathology accreditation, and scanner generation specifications protect patients from diagnostic delays.
Key Takeaways
- AERB registry lookup confirms which Haryana centers hold valid PET-CT licensing and documents scanner models like GE Discovery IQ 2 digital TOF
- Time-of-flight PET-CT scanners improve lesion detection sensitivity for sub-centimeter nodules compared to non-TOF systems
- 3-D digital mammography (tomosynthesis) detects 20-65% more invasive breast cancers in dense tissue than conventional 2-D mammography
- NABL accreditation verifies pathology labs meet ISO 15189 standards for biopsy quality controls and turnaround protocols
- Government day-care cancer centres at 22 district hospitals provide chemotherapy access but advanced imaging remains concentrated in private tertiary centers
Why Advanced Diagnostic Equipment Matters for Early Cancer Detection
Verifying which Haryana screening centers offer genuinely advanced diagnostic equipment requires checking three markers: AERB licensing for nuclear medicine facilities, scanner generation (TOF PET-CT vs conventional, 3-D vs 2-D mammography), and lab accreditation. Centers like Andromeda Cancer Hospital document specific equipment — the GE Discovery IQ 2 PET-CT scanner and 3-D full-field digital mammography — but many facilities use generic 'advanced diagnostics' claims without publishing scanner models or accreditation certificates. India's estimated 2.72 million active cancer cases intensify demand for early detection infrastructure across Haryana and Delhi-NCR.
How Equipment Quality Affects Diagnostic Sensitivity
Time-of-flight (TOF) PET-CT scanners deliver higher lesion-detection sensitivity than non-TOF models, particularly for sub-centimeter nodules in lung and lymph nodes. Similarly, 3-D mammography (tomosynthesis) reduces tissue-overlap masking that causes missed findings on conventional 2-D views. Facilities publishing specific scanner models — Apollo's screening package includes mammography/tomogram imaging — allow prospective patients to verify detection capability before booking. Equipment generation directly determines what early-stage cancers a center can reliably identify.
Turnaround Time and Treatment Delay Risks
In-house imaging typically shortens report turnaround versus outsourced pathways; same-day or next-day PET-CT reporting contrasts with multi-day waits when scans travel to regional labs. Treatment initiation windows narrow when delays extend beyond guideline thresholds — particularly for aggressive subtypes. However, report speed varies by case complexity and institutional workflow; urgency protocols and staffing constraints influence actual turnaround. Prospective patients should confirm both equipment specifications and typical reporting timelines during center evaluation.
Understanding equipment standards begins with regulatory verification, the foundation that separates compliant facilities from those operating outside legal frameworks.
AERB Licensing: the Non-Negotiable Standard for Pet-Ct and Nuclear Medicine
What AERB Licensing Proves About Radiation Safety
The Atomic Energy Regulatory Board (AERB) certifies PET-CT facilities across India, verifying that each center meets stringent safety protocols for handling radioactive materials. Licensing confirms three critical components: scanner hardware meets radiation containment standards, technicians hold radiation-safety certification, and the facility implements documented quality-control protocols. Without AERB approval, a center cannot legally operate PET-CT equipment, yet screening program infrastructure gaps mean patients must verify claims rather than assume compliance. The registry exists as a public accountability tool, publishing every licensed facility by name, district, and equipment model.
Andromeda Cancer Hospital appears in the AERB registry with GE Discovery IQ 2 digital TOF scanner certification, one documented case among Haryana's licensed centers. When a facility advertises PET-CT capability but does not appear in the public list, request written proof of AERB licensing before payment; absence from the registry signals non-compliant radiation safety. The verification step takes two minutes and eliminates guesswork.
Step-By-Step: Using the AERB Registry to Verify a Center
Follow this numbered sequence to confirm any Haryana center's PET-CT licensing status before booking:
- Access the AERB licensing registry at www.aerb.gov.in, the PDF is titled "List of PET-CT Centres licensed by AERB (as on May 20, 2026)".
- Download the current list and open the PDF in a reader that supports text search (Ctrl+F or Cmd+F).
- Search for the facility name exactly as advertised, or filter by district, Haryana entries include Jhajjar, Gurgaon, Faridabad, Sonipat, and Hisar.
- Confirm the licensing date and status in the registry entry. If the facility does not appear, request written AERB licensing documentation from the center before proceeding with payment, unlicensed operation is prohibited, and absence from the list is your pre-booking red flag.
The registry lists nine AERB-certified PET-CT centers across Haryana as of May 2026, including National Cancer Institute (Jhajjar), Fortis Hospotel (Gurgaon), House of Diagnostics (Faridabad), Metro Specialty Hospitals (Faridabad), Andromeda Hospital and Research Centre (Sonipat), Scan4Health (Gurgaon), and HKSD Sarvodaya Health Care (Hisar). When a center advertises PET-CT capability but you cannot locate its name in the PDF, that discrepancy is not administrative lag, it is a licensing gap that should pause your decision until you receive documented proof of AERB approval. The two-minute lookup protects you from booking scans at facilities that cannot legally operate the equipment.
Beyond licensing verification, the specific imaging technologies a center deploys determine diagnostic accuracy for different cancer types.
Key Imaging Technologies to Look for in a Cancer Screening Center
When evaluating cancer screening centers in Haryana, asking "Do you have PET-CT?" is insufficient. Scanner generation, detector technology, and biopsy equipment directly affect diagnostic accuracy, staging precision, and patient experience. This section explains three critical technology categories that separate current-generation facilities from older infrastructure.
Pet-Ct Scanner Generation: Digital TOF Vs Older Systems
Time-of-flight (TOF) imaging represents a fundamental advance in PET-CT technology. Digital TOF scanners measure the precise time photons take to travel between detectors, enabling the system to localize metabolic activity with greater spatial accuracy. This technology delivers exceptional clarity, even for small or low-contrast lesions, critical when staging early-stage cancer or monitoring treatment response. Andromeda Cancer Hospital operates the GE Discovery IQ 2 PET-CT system, a digital TOF scanner that reduces scan time while improving lesion detection sensitivity compared to older non-TOF models. When comparing centers, verify the specific scanner model and ask whether the system uses digital TOF technology, a "PET-CT available" claim on a Google listing does not specify whether the facility operates a current-generation scanner or legacy equipment installed a decade ago.
Mammography: 3-D Digital Tomosynthesis Vs 2-D Film
3-D digital mammography (tomosynthesis) addresses the core limitation of 2-D mammography: overlapping breast tissue that obscures small lesions, particularly in dense breast tissue. Tomosynthesis captures multiple thin-slice images of the breast, allowing radiologists to examine tissue layer by layer rather than interpreting a single compressed image. Clinical data shows 20 to 65% improvement in invasive breast cancer detection in dense breast tissue when using 3-D mammography compared to 2-D systems. Andromeda Cancer Hospital provides 3-D full-field digital mammography as part of its breast oncology diagnostic facilities. When evaluating screening centers, confirm whether the mammography system is 3-D tomosynthesis or conventional 2-D film, many centers still operate older 2-D equipment, which may miss small lesions in patients with dense breast tissue.
Stereotactic Breast Biopsy and Patient Comfort Features
Vacuum-assisted stereotactic breast biopsy reduces sampling error compared to traditional core needle biopsy by removing larger, continuous tissue samples under precise 3-D image guidance. This technique is particularly important for microcalcifications and non-palpable lesions that cannot be accurately targeted with ultrasound alone. Andromeda Cancer Hospital offers stereotactic breast biopsy with a dedicated biopsy chair, a patient comfort feature that allows the procedure to be performed with the patient lying face-down rather than sitting upright, reducing anxiety and movement artifacts that can compromise sample accuracy. When comparing screening centers, ask whether stereotactic biopsy is performed with a vacuum-assisted device and whether the facility uses a dedicated biopsy chair or requires patients to remain seated during the procedure.
Imaging technology represents only half the diagnostic equation, pathology lab accreditation validates the tissue analysis that confirms or rules out malignancy.
Pathology Lab Accreditation: NABL and CAP Standards in Haryana
What NABL Accreditation Verifies for Biopsy Quality
NABL (National Accreditation Board for Testing and Calibration Laboratories) grants accreditation to medical laboratories under ISO 15189, certifying that the lab meets standardized protocols for specimen handling, turnaround reporting, quality control, and proficiency testing participation. Accredited pathology labs must demonstrate consistent performance across mandatory parameters, from sample preservation through final histopathology reports, ensuring that biopsy interpretations are reproducible and clinically reliable.
Patients scheduling diagnostic procedures can verify a center's current NABL pathology accreditation by searching the official NABL directory before biopsy booking. Unlike competitor listings that name facilities without explaining verification steps, this directory confirms which labs hold active ISO 15189 certification, clarifying the quality assurance layer behind each diagnostic report.
In-House Vs Partner Lab Models for IHC and Molecular Testing
Cancer centers in Haryana adopt two primary pathology models: some operate fully integrated in-house NABL-accredited labs, while others partner with accredited external laboratories for specialized tests like immunohistochemistry (IHC) and molecular profiling. Andromeda Cancer Hospital currently outsources IHC and advanced molecular testing to accredited partner laboratories, with an in-house IHC facility under development; this transparent partnership model ensures access to high-quality testing while the internal capability is established.
In contrast, centers like House of Diagnostics maintain direct NABL accreditation for on-site pathology services, reducing inter-lab coordination time for routine histopathology. Both models, in-house accreditation and accredited-partner networks, can deliver ISO 15189, compliant reports when the underlying laboratory holds valid certification. Patients should confirm which testing modalities (routine histopathology, IHC, next-generation sequencing) are performed on-site versus outsourced, then cross-check the partner lab's accreditation status on nabl-india.org before consenting to biopsy procedures.
Multi-site cancer care ecosystems, such as those described by Max Institute of Cancer, also rely on networked pathology partnerships to consolidate diagnostic expertise across surgical, radiation, and medical oncology disciplines, reinforcing that accredited-partner models are a standard arrangement in tertiary oncology settings.
Armed with knowledge of regulatory standards and equipment specifications, patients can now execute systematic verification before committing to a screening appointment.
How to Verify a Center's Equipment Claims Before Your Appointment
Given that cancer is the second leading cause of mortality worldwide and accounts for a substantial proportion of deaths in India, patients must verify that screening centers possess the regulatory licenses and technical capabilities they claim. Verbal assurances without documentation signal compliance risk; this section provides a four-step verification checklist you can execute before booking.
Pre-Appointment Verification Checklist
- AERB registry lookup for PET-CT licensing, Unlicensed centers cannot legally operate PET-CT scanners. Verify the center's AERB license number on the Atomic Energy Regulatory Board's public registry before payment. Andromeda Cancer Hospital operates an AERB-certified PET-CT facility equipped with the GE Discovery IQ 2 system.
- NABL directory check for pathology accreditation, Pathology labs without National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation may lack standardized quality controls for biopsy processing and immunohistochemistry. Dr. Pansi Gupta at Andromeda was trained in NABL accreditation, and the hospital ensures access to high-quality advanced molecular testing through tie-ups with accredited laboratories.
- CGHS empanelment verification, For beneficiaries of the Central Government Health Scheme (CGHS), confirm current empanelment status on cghshospitals.com before admission rather than assuming a center listed last year is still empaneled. Hospitals may gain or lose empanelment; North Delhi Advanced Diagnostic & MRI Centre is a CGHS empanelled diagnostic in Delhi that provides healthcare services to CGHS beneficiaries including central government employees, pensioners, and their dependents.
- Written proof request before payment, Request written documentation of AERB licensing and NABL accreditation before making payment. Verbal claims without certificates signal non-compliance risk.
CGHS Empanelment Verification for Haryana Beneficiaries
Many insurers deny PET-CT claims for screening or non-oncologic uses; CGHS beneficiaries should confirm coverage for their specific indication before booking. The CGHS empanelment database at cghshospitals.com lists facilities reviewed by the Quality Council of India for healthcare quality. Empanelment does not guarantee oncology services are included, some hospitals are empaneled for general care only. Confirm that oncology services appear in the hospital's empanelment certificate before scheduling a cancer screening appointment.
Questions to Ask Centers About Equipment Specs
- What PET-CT scanner model do you operate?, Time-of-flight (TOF) digital PET-CT systems (e.g., GE Discovery IQ 2) deliver higher image resolution and lower radiation dose than older analog scanners. Ask for the manufacturer name and model year.
- Is your pathology lab NABL-accredited or outsourced?, In-house NABL-accredited labs typically return frozen-section results within 20 to 30 minutes during surgery and radical surgery histopathology reports within 7 to 10 days. Outsourced labs may introduce multi-day delays.
- What is your report turnaround commitment for PET-CT and biopsy results?, Andromeda Cancer Hospital provides same-day or next-day PET-CT reporting. Centers without written turnaround commitments may delay treatment planning by weeks.
Learn more about low cancer screening rates in India and government programs addressing this challenge: Cancer Screening Rates Low in India, Government Programs.
While private tertiary centers concentrate advanced imaging infrastructure, understanding Haryana's public cancer care network reveals complementary access points for treatment delivery.
Government and Charitable Cancer Screening Infrastructure in Haryana
Day Care Cancer Centres at District Hospitals: What They Offer
On World Cancer Day 2024, the Haryana government launched Day Care Cancer Centres at 22 district civil hospitals across the state. These centres follow a hub-and-spoke model, with National Cancer Institute Jhajjar, PGIMS Rohtak, Sarvodaya Hospital Faridabad, and Atal Cancer Care Centre Ambala Cantt acting as hubs. The centres offer follow-up chemotherapy, palliative care, symptom management, and post-treatment support. In 2025, over 20,000 patients attended OPD at the five operational DCCCs, demonstrating significant chemotherapy access expansion. However, these district hospitals focus on treatment delivery, they do not offer PET-CT or advanced imaging equipment. Patients seeking PET-CT must access tertiary private centers or reference the AERB registry for licensed facilities.
Where to Access Pet-Ct and Advanced Imaging in Haryana
While district hospitals provide basic CT and MRI services at some locations, advanced diagnostic imaging like PET-CT remains concentrated in private tertiary centers. PGIMS Rohtak's state-of-the-art cancer diagnostics and radiotherapy facility, intended to house PET scans, bone scans, linear accelerators, and CyberKnife technology, has remained non-functional for three years due to non-procurement of critical medical equipment and absence of fresh financial approvals. Until public infrastructure gaps close, patients must rely on private centers with AERB-licensed PET-CT systems. The AERB registry serves as the verification tool for identifying facilities offering advanced imaging in Haryana.
Making Informed Choices in Haryana's Cancer Screening Landscape
Government day-care cancer centres expand chemotherapy access across 22 Haryana districts but don't offer PET-CT or advanced imaging, patients seeking early-stage detection must access tertiary private centers with AERB-licensed equipment. This infrastructure divide means screening decisions hinge on verifiable equipment credentials rather than proximity or cost alone.
As India's cancer burden grows to 1.56 million new cases annually, standardized equipment verification through AERB and NABL registries will become the non-negotiable baseline for informed patient choice in Haryana and beyond. Registry-driven transparency shifts decision power from marketing narratives to regulatory compliance.
Verify your chosen cancer screening center's AERB PET-CT licensing and NABL pathology accreditation this week using the public registries, or explore Andromeda Cancer Hospital's documented equipment credentials as one AERB-listed example of digital TOF PET-CT and 3-D mammography infrastructure.
Frequently Asked Questions
How do I verify if a cancer screening center in Haryana has an AERB-licensed PET-CT scanner?
Download the current AERB registry from www.aerb.gov.in/images/PDF/NuclearMedicine/RSD1.pdf, search for the facility name or district, and confirm licensing status plus scanner model. Andromeda Cancer Hospital appears in the registry with GE Discovery IQ 2 digital TOF certification. Facilities not listed operate without regulatory approval.
Does CGHS cover PET-CT scans at private cancer screening centers in Haryana?
Many insurers deny PET-CT claims for screening or non-oncologic uses, CGHS beneficiaries must verify coverage for their specific indication before booking. Check empanelment status at cghshospitals.com, which lists facilities reviewed by the Quality Council of India. Pre-authorization prevents claim rejection after the scan.
What is the difference between digital TOF and non-TOF PET-CT scanners for cancer detection?
Digital time-of-flight (TOF) PET-CT scanners measure precise photon travel time between detectors, localizing metabolic activity with greater spatial accuracy than non-TOF systems. TOF technology improves lesion detection sensitivity for sub-centimeter nodules and reduces scan time. Ask centers which scanner model they operate before booking.
How can I check if a pathology lab is NABL-accredited before a cancer biopsy?
Search the lab's name at nabl-india.org to confirm current accreditation status under ISO 15189. NABL accreditation verifies quality controls, standardized turnaround protocols, and proficiency testing compliance. Both in-house NABL labs and accredited-partner networks deliver ISO-compliant reports when properly certified.
Do government day-care cancer centres in Haryana offer PET-CT or advanced imaging?
The 22 district hospital Day Care Cancer Centres launched in 2024 focus on chemotherapy delivery, not advanced imaging. They served over 20,000 OPD patients in 2025 through a hub-and-spoke model. PET-CT access requires tertiary private centers listed in the AERB registry.
Why does 3-D mammography matter for breast cancer screening in Haryana?
3-D digital mammography (tomosynthesis) captures thin-slice images that detect 20-65% more invasive breast cancers in dense tissue than 2-D mammography. Tomosynthesis examines tissue layer-by-layer, reducing overlapping-tissue obscuration. Ask centers whether they offer true 3-D tomosynthesis or conventional 2-D systems.
What questions should I ask a cancer screening center about their equipment before booking?
Request the PET-CT scanner model (TOF vs non-TOF), mammography type (3-D vs 2-D), pathology lab NABL status, and report turnaround commitment. Ask for written AERB and NABL proof before payment. Verifying these markers protects against marketing claims unsupported by regulatory documentation.
Sources
- Implementing cancer prevention strategies in India: progress, persistent challenges and future directions - ecancer - ecancer.org
- Apollo ProHealth Cancer Screening - Apollo Athenaa Women cancer Centre | Apollo Hospitals - www.apollohospitals.com
- List of PET-CT Centres licensed by AERB (as on May 20, 2026) - aerb.gov.in (2026)
- a scoping review of breast and cervical cancer programs - pmc.ncbi.nlm.nih.gov
- Cancer Hospital Delhi | Surgical Oncology Centre | Dharamshila Narayana Hospital - www.google.com
- NABL India - nabl-india.org
- Top 10 Cancer Hospitals in Delhi: Government and Private - www.careinsurance.com
- North Delhi Advanced Diagnostic & MRI Centre - cghshospitals.com
- Determinants of Cancer Screening in India - PMC - pmc.ncbi.nlm.nih.gov
- Haryana govt launches Day Care Cancer Centres at 22 district hospitals - hindustantimes.com (2024)
- Cancer care buildings remain idle over funds delay, non-functional infrastructure in Rohtak | Chandigarh News - The Indian Express - indianexpress.com (2026)
- Best Cancer Hospital in Delhi NCR, India: Book Oncologist ... - www.maxhealthcare.in